Thursday, November 21, 2024

Nathalie Bougenies

Nathalie practices corporate law, intellectual property, and cannabis law, focusing on the regulatory framework of hemp-derived CBD products. She enjoys building a deep understanding of our clients’ businesses, industries, and long-term visions, and leverages her broad expertise and international background to help our overseas companies with their foreign direct investment into the United States and to help American companies with their overseas legal needs.

other Featured Stories

Posts

Congress Takes Issue With The DEA Hemp Rule

The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule.

CBD Cosmetics: Unregulated, Yes. Risk-Free, No.

Even if CBD-infused cosmetics represent the lowest level of risk for companies, safety and labeling requirements still exist under federal and state law.

The Hemp Industry Responds To The DEA Rule With A Lawsuit

Petitioners claim that a recent DEA rule is unlawful because it exceeds the DEA’s authority and violates the 2018 Farm Bill.

A Bipartisan Bill Would Regulate Hemp CBD As A Dietary Supplement

The passage of this bipartisan bill would help raise the quality and safety of hemp products, and thus, protect consumers.

DEA Interim Final Rule: What Is ‘Synthetically Derived THC’?

Based on the information found in the DEA regulations and publications, it appears the agency refers to the ordinary meaning of “synthetic.”

FDA Guidance On Cannabis Research: A Glimpse Of What’s To Come For CBD Products?

This guidance is merely a reflection of the FDA’s current thinking on the manufacturing and testing of hemp-derived drugs.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.